These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30805710)

  • 1. Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer.
    Sakaue T; Koga H; Iwamoto H; Nakamura T; Ikezono Y; Abe M; Wada F; Masuda A; Tanaka T; Fukahori M; Ushijima T; Mihara Y; Naitou Y; Okabe Y; Kakuma T; Ohta K; Nakamura KI; Torimura T
    Med Mol Morphol; 2019 Dec; 52(4):198-208. PubMed ID: 30805710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of CD133-positive extracellular membrane vesicles in pancreatic cancer ascites and beyond.
    Fargeas CA; Karbanová J; Corbeil D
    Med Mol Morphol; 2020 Mar; 53(1):60-62. PubMed ID: 30953194
    [No Abstract]   [Full Text] [Related]  

  • 3. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features.
    Ni T; Wang H; Zhan D; Tao L; Lv M; Wang W; Chu Z; Zhou Z; Sunagawa M; Liu Y
    Life Sci; 2021 Mar; 269():119021. PubMed ID: 33450261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
    Hu Y; Qi C; Liu X; Zhang C; Gao J; Wu Y; Yang J; Zhao Q; Li J; Wang X; Shen L
    Cancer Lett; 2019 Aug; 457():142-150. PubMed ID: 31075288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics.
    Li D; Su D; Xue L; Liu Y; Pang W
    Int J Clin Exp Pathol; 2015; 8(9):11218-23. PubMed ID: 26617845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line.
    de Maria S; Santoro A; Fuggetta MP; Rocchetti R; Cottarelli A; Lanzilli G; Stiuso P; Angelico G; Spadola S; Franco Zannoni G; Rubini C; Emanuelli M; Carmela Pedicillo M; Pannone G; Muzio LL
    APMIS; 2020 Dec; 128(12):637-646. PubMed ID: 32911563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
    Kim TM; Ko YH; Ha SJ; Lee HH
    BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ascites derived exosomes on the stemness and invasion ability of ovarian cancer stem-like cell].
    Chen SP; Xia YF; Jiang HH; Sun WY; Lou YH
    Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):349-357. PubMed ID: 34034422
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer stem cell markers and exosomes - the incentive push.
    Heiler S; Wang Z; Zöller M
    World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells.
    Maeda K; Ding Q; Yoshimitsu M; Kuwahata T; Miyazaki Y; Tsukasa K; Hayashi T; Shinchi H; Natsugoe S; Takao S
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27367674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
    Kanwal R; Shukla S; Walker E; Gupta S
    Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
    Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
    World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer.
    Lee HH; Seo KJ; An CH; Kim JS; Jeon HM
    J Surg Oncol; 2012 Dec; 106(8):999-1004. PubMed ID: 22674531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond.
    Soleimani A; Dadjoo P; Avan A; Soleimanpour S; Rajabian M; Ferns G; Ryzhikov M; Khazaei M; Hassanian SM
    Life Sci; 2022 Mar; 293():120050. PubMed ID: 35026215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.